• Study on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium The Netherlands

  • Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Estonia Finland France Germany +6

  • Study comparing chemotherapy with or without radiation therapy in patients with resectable gastroesophageal junction cancer using docetaxel, oxaliplatin, fluorouracil and calcium folinate

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of Trastuzumab, Pertuzumab, and Chemotherapy Combination with Response-Guided Treatment for Patients with HER2-Positive Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effects and Safety of Buloxibutid for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Drugs:
    Austria Belgium Germany Greece Italy Poland

  • Study on Bevacizumab and Drug Combination for Patients with Resectable Colorectal Peritoneal Metastases

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium The Netherlands

  • Study of Ivosidenib and Azacitidine for Patients Aged 18 and Older with Untreated Acute Myeloid Leukemia with IDH1 Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Spain

  • Study on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Finland Germany Lithuania +3

powered by